Remitly Global RELY 深 沪
等待开盘 10-01 09:30:00 美东时间
21.34
-0.130
-0.61%
华盛通- 最 高21.635
- 今 开21.63
- 成交量 309.92万股
- 最 低 21.275
- 昨 收 21.47
- 总市值 45.17亿
- 52周最高 27.479
- 市盈率 静 68.35
- 换手率 1.46%
- 52周最低 12.08
- 委 比 -13.91%
- 总股本 2.12亿
- 历史最高 53.65
- 量 比 0.73
- 振 幅 1.68%
- 历史最低 6.66
- 每 手 1
- 风险率 4.33%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Remitly partners with Etsy to give sellers more choice in how they get paid globally
Remitly partners with Etsy to offer local payment options for new sellers in 15 countries. Starting this fall, Etsy sellers can choose Remitly as their payout provider, enabling them to hold earnings in USD, convert to local currencies, and deposit funds directly to bank accounts or mobile wallets. This marks Remitly's expansion into supporting small and medium businesses globally, building on its trusted cross-border payment network.
09-09 13:00
美股大行评级 | 瑞杰金融维持英伟达"强力买入"评级，目标价从330美元升至352美元；瑞穗下调美光科技目标价从1375美元降至1300美元
今日重点评级关注：摩根大通：维持Ultragenyx Pharmaceutical"超配"评级，目标价从75美元升至80美元；瑞杰金融：维持英伟达"强力买入"评级，目标价从330美元升至352美元
08-26 08:37
Wolfe Research Maintains Outperform on Remitly Global, Raises Price Target to $32
Wolfe Research analyst Darrin Peller maintains Remitly Global (NASDAQ:RELY) with a Outperform and raises the price target from $31 to $32.
08-25 23:11
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
美股大行评级 | 花旗、富国下调闪迪目标价，低至1400美元；百济神州、多邻国、DoorDash、Shopify等获多家机构上调评级
今日重点评级关注：康托·菲茨杰拉德：维持EyePoint"超配"评级，目标价从47美元升至55美元；伯恩斯坦：维持Figure Technology"跑赢大市"评级，目标价从67美元升至70美元
08-07 13:41
Remitly Announces Upcoming Webinar and Investor Conference Participation
Remitly Global announced that its CEO Sebastian Gunningham and CFO Vikas Mehta will participate in several investor conferences in August and September 2026. They will attend a webinar hosted by William Blair on August 10, the Keybanc Technology Leadership Forum on August 11, a fireside chat at the Goldman Sachs Communacopia + Technology Conference on September 9, and the FT Partners FinTech Conference and Oppenheimer Fintech Leaders Conference o...
08-07 13:00
Keybanc Maintains Overweight on Remitly Global, Raises Price Target to $33
Keybanc analyst Alex Markgraff maintains Remitly Global (NASDAQ:RELY) with a Overweight and raises the price target from $28 to $33.
08-06 22:20
美股夜盘 | SiTime Corporation暴升32.41%，SoundHound AI暴升23.17%
SiTime Corporation暴升32.41%；SoundHound AI暴升23.17%；Caris Life Sciences劲升12.22%
08-06 15:01
美股夜盘 | SiTime Corporation暴升32.82%，SoundHound AI暴升24.57%
SiTime Corporation暴升32.82%；SoundHound AI暴升24.57%；Paycom Software劲升13.17%
08-06 13:01
Remitly Global Q2 EPS $0.93 Beats $0.13 Estimate, Sales $495.156M Beat $485.446M Estimate
Remitly Global (NASDAQ:RELY) reported quarterly earnings of $0.93 per share which beat the analyst consensus estimate of $0.13 by 615.38 percent. This is a 3000 percent increase over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $495.156 million ...
08-06 04:19
